A lead assembly and a method of making a lead are provided. The lead comprises a terminal, proximal end having a plurality of terminal contacts and material separating the terminal contacts. In one embodiment of the lead, the terminal contacts are separated by a preformed spacer, that may be made from various hard materials such as polyurethane, PEEK and polysulfone. Epoxy may be used to fill spaces at the proximal lead end, including between the spacer and terminal contacts. In one embodiment of the lead, the terminal contacts are separated by epoxy only. The lead may include a plurality of conductor lumens that contain conductors. The lead may also include a stylet lumen for accepting a stylet.

Patent
   8019439
Priority
Jan 11 2005
Filed
Mar 22 2007
Issued
Sep 13 2011
Expiry
Nov 11 2028
Extension
1035 days
Assg.orig
Entity
Large
284
11
all paid
11. A stimulation lead having a proximal end, a distal end and an insulative covering, the lead comprising:
a plurality of electrode contacts on the distal end of the stimulation lead;
a plurality of conductive terminal contacts at the proximal end of the stimulation lead;
a lead body extending along a substantial length of the stimulation lead, the lead body defining a plurality of conductor lumens and a stylet lumen, wherein the plurality of conductor lumens and the stylet lumen extend along a length of the lead body, wherein the plurality of conductor lumens comprises a first conductor lumen and a second conductor lumen;
a plurality of conductor wires, each conductor wire of the plurality of conductor wires connecting a different one of the plurality of conductive terminal contacts to one of the electrode contacts, wherein the plurality of conductor wires comprises a first conductor wire and a second conductor wire, wherein the first conductor wire extends along the first conductor lumen and the second conductor wire extends along the second conductor lumen;
a terminal spacer that is positioned between a first and a second adjacent terminal contacts of the plurality of conductive terminal contacts; and
epoxy that is within at least some portion of the plurality of conductor lumens in proximity to the proximal end of the stimulation lead.
1. A method of making a stimulation lead having a proximal end and a distal end, the method comprising:
placing a plurality of conductive terminal contacts at the proximal end of the stimulation lead;
placing a plurality of electrode contacts at the distal end of the stimulation lead;
connecting a plurality of conductor wires to the plurality of terminal contacts such that for each of the plurality of terminal contacts a different conductor wire of the plurality of conductor wires connects to the terminal contact, wherein the plurality of conductor wires comprises a first conductor wire and a second conductor wire, wherein the first conductor wire extends within a first conductor lumen of a plurality of conductor lumens defined in a lead body of the stimulation lead, wherein the second conductor wire extends within a second conductor lumen of the plurality of conductor lumens defined in the lead body of the stimulation lead, wherein the lead body defines a stylet lumen configured and arranged for receiving a stylet, and wherein the plurality of conductor lumens and the stylet lumen each extend along a substantial length of the stimulation lead from the proximal end;
placing a terminal spacer between a pair of adjacent conductive terminal contacts of the plurality of conductive terminal contacts;
and
applying epoxy to the proximal end of the stimulation lead such that the epoxy at least partially fills the conductor lumens in proximity to the proximal end of the stimulation lead.
26. A stimulation lead having a proximal end and a distal end and an insulative covering, the lead comprising:
a plurality of electrode contacts on the distal end of the stimulation lead;
a plurality of conductive terminal contacts disposed at the proximal end of the stimulation lead, the plurality of conductive terminal contacts comprising a first conductive terminal contact and a second conductive terminal contact;
a lead body extending along a substantial length of the stimulation lead, the lead body defining a plurality of conductor lumens and a stylet lumen, wherein the plurality of conductor lumens and the stylet lumen extend along a length of the lead body, wherein the plurality of conductor lumens comprises a first conductor lumen and a second conductor lumen;
a plurality of conductor wires, each conductor wire of the plurality of conductor wires connecting a different one of the plurality of conductive terminal contacts to one of the plurality of electrode contacts, wherein the plurality of conductor wires comprises a first conductor wire and a second conductor wire, wherein the first conductor wire extends along the first conductor lumen and the second conductor wire extends along the second conductor lumen;
a terminal spacer that is positioned between the first and the second terminal contacts, wherein the terminal spacer is selected from the group consisting of PEEK and polysulfone; and
epoxy disposed within at least some portion of the plurality of conductor lumens in proximity to the proximal end of the stimulation lead.
2. The method of claim 1, wherein the terminal spacer is made from material selected from the group consisting of polyetherether ketone, polyarylether ketone (collectively, PEEK) and polysulfone.
3. The method of claim 1, wherein the terminal spacer is made from polyurethane.
4. The method of claim 1, wherein the distal end of the lead is configured as a paddle and wherein the lead is a paddle lead.
5. The method of claim 1, wherein the distal end of the lead is configured as linear and wherein the lead is a percutaneous, linear lead.
6. The method of claim 1, wherein the epoxy has a durometer of at least 85D, and wherein the lead body has a durometer that is no more than 55D.
7. The method of claim 1, wherein the stimulation stylet lumen is defined in the lead body such that the plurality of conductor lumens surrounds the stylet lumen.
8. The method of claim 1, wherein the plurality of terminal contacts are in the form of rings having at least one slot on the edge of the ring.
9. The method of claim 1, wherein the terminal spacer is made from material selected from the group consisting of silicone, polyethylene and polyester.
10. The method of claim 1, further comprising attaching a proximal tip to the proximal end of the stimulation lead after applying the epoxy to the proximal end of the stimulation lead.
12. The lead of claim 11, wherein the terminal spacer is made from a material selected from the group consisting of PEEK and polysulfone.
13. The lead of claim 11, wherein the epoxy has a durometer of at least 85D, and wherein the lead body has a durometer that is no more than 55D.
14. The lead of claim 11, wherein the terminal spacer is made from the material selected from the group consisting of polyester, polyethylene, and silicone.
15. The lead of claim 11, wherein the lead body is a one-piece component made from thermoplastic polyurethane.
16. The lead of claim 11, wherein the stylet lumen is defined in the lead body such that the plurality of conductor lumens surrounds the stylet lumen.
17. The lead of claim 11, wherein the plurality of terminal contacts are in the form of cylindrical rings having at least one slot on the edge of the cylindrical ring.
18. The lead of claim 11, wherein the distal tip of the lead includes a radiopaque marker.
19. The lead of claim 11, wherein at least one of the plurality of conductor wires is a multi-filar conductor wire.
20. The lead of claim 11, wherein the distal end of the lead is linear and the lead is percutaneous.
21. The lead of claim 11, wherein distal end of the lead is configured as a paddle and wherein the lead is a paddle lead.
22. The lead of claim 11, further comprising: a retention sleeve disposed on the proximal end of the stimulation lead, the retention sleeve configured to contact a set screw.
23. The lead of claim 11, wherein the plurality of electrode contacts are configured as rings.
24. The stimulation lead of claim 11, further comprising a proximal tip covering an injection aperture defined at the proximal end of the lead.
25. The stimulation lead of claim 11, wherein each conductor wire of the plurality of conductor wires extends within a different conductor lumen of the plurality of conductor lumens.
27. The stimulation lead of claim 26, wherein epoxy is placed between the terminal spacer and either the first terminal contact or the second terminal contact, and wherein epoxy is placed within voids in the stimulation lead inside the terminal spacer and inside at least one of the terminal contacts.
28. The stimulation lead of claim 26, wherein the plurality of conductor lumens and the stylet lumen are defined in a one-piece component.

This application is a continuation-in-part of U.S. patent application Ser. No. 11/329,907, filed Jan. 11, 2006, now U.S. Pat. No. 7,891,085, which claims the benefit of provisional application Ser. No. 60/643,093, filed Jan. 11, 2005. Both the '907 and '093 applications are herein incorporated by reference in their entireties.

The present invention relates to implantable leads for providing electrical stimulation.

Many types of implantable leads are currently used to treat a variety of maladies. In one example, a multiple electrode contact lead is used to treat chronic pain through stimulation of the spinal cord. “Electrode contact” will be used herein to refer to that conductive surface on the lead that delivers or sinks electrical current to or from tissue. Typical electrode contact material are platinum or platinum/iridium alloy.

Spinal cord stimulation systems generally have two implantable components: an implantable pulse generator (IPG) and at least one stimulation lead connected to one output of the IPG. Generally, however, the IPG is a multi-channel device capable of delivering electrical current through the multiple electrode contacts of the lead.

The term “lead” used herein will refer generally to any elongate device having any conductor or conductors, covered with an insulated sheath and having at least one terminal (connector) contact attached to the elongate device, usually at the proximal portion of the elongate device. As broadly used, the term “lead” may refer to a “stimulation lead” such as a percutaneous or linear lead, a paddle type lead, an extension lead or an adapter lead, which is a type of extension lead. A stimulation lead may have a stylet lumen running through most of the length of the lead and which lumen has an opening at the proximal end of the lead. A stylet, which is a thin wire or wire-like implement made from metal or some other stiff and resilient material, e.g., ceramic or plastic, may be placed into the stylet lumen during steering and implantation of the lead. The stylet, inserted into the lumen, can help stiffen the lead so that the stylet/lead combination may be more easily inserted through tissue. After the lead is positioned at a desired location in the body, the stylet is withdrawn from the stylet lumen and then the stylet is typically discarded.

There are two types of stimulation leads that may be used with the IPG. The first type of stimulation lead is a paddle lead, which has a multiplicity of electrode contacts spread out over a flat, paddle-like surface that is attached to one end of the lead. A paddle lead advantageously permits the electrode contacts to be spaced apart to provide wide coverage over a stimulation area. A disadvantage presented with a paddle lead is that it usually requires a laminectomy or laminotomy, which are highly invasive surgical procedures necessary to implant the large, non-isodiametric paddle.

A second type of stimulation lead is commonly used is a “percutaneous” or “linear” lead, having multiple electrode contacts positioned along the distal portion of the lead. U.S. Pat. No. 6,205,361 issued to Baudino et al., for example, describes the making of a multi-contact electrode array for a lead. The distal end of the lead may be about the same thickness or diameter as the remainder of the lead. Such a lead is sometimes also referred to as an “isodiametric” lead because the lead may have the same thickness or, in the case of a lead have a circular cross-section, the same diameter, along the length of the lead. The percutaneous (linear) lead is dimensionally configured for tunneling to a target stimulation site. No invasive surgical procedure such as a laminotomy is required; the percutaneous lead may be placed through an epidural type large-bore needle reducing surgical trauma.

Whether the lead is a stimulation lead such as a paddle type or a percutaneous lead or whether the lead is an extension lead or an adapter type lead, it is sometimes desired to control the stiffness and flexibility of the proximal (terminal or connector) portion of the lead relative to the remainder of the lead.

It would be desirable to have designs and methods for making the proximal (terminal) connector portion of a lead having multiple terminal contacts, which designs and methods yield a connector portion with a desired stiffness, flexibility and buckling resistance.

Embodiments of lead designs, with specific proximal connector ends, and methods of manufacturing these lead designs are provided. The proximal end of the lead has at least two terminal contacts for connecting to a connector block of an IPG, which connector block accepts insertion of the proximal (connector) end of the lead. The distal portion of the lead can be any configuration including a linear or percutaneous design or a paddle type design or the female connector or receptacle of an extension lead or an adapter lead.

The proximal portion of every lead always has a connector end with a plurality of terminal contacts as part of the connector. As an example, the connector may have eight terminal contacts. In one embodiment, a terminal spacer is placed between adjacent terminal contacts. Small spaces and voids between the terminal spacer and terminal contacts are filled up using an implantable grade epoxy which is allowed to harden during manufacture of the lead. The terminal spacers can be chosen from a number of implantable materials to yield a desired mechanical characteristic for the proximal (terminal or connector) end of the lead. The terminal spacers may be chosen from among the following implantable materials: polyurethane, polyetherether ketone or polyarylether ketone (both types of ketones, collectively referred to hereinafter as “PEEK”), polysulfone, polyester, polyethylene or silicone. The terminal spacers can be ring shaped or ring-like in configuration and can be pre-formed. The terminal contacts can also be ring shaped or ring-like in configuration.

In another embodiment, the proximal portion of the lead has a plurality of terminal contacts. Thus the lead may have two, three or more terminal contacts. No terminal spacers are used at the proximal end of the lead. The terminal contacts are spaced apart by a specified distance. Epoxy is placed between two terminal contacts and allowed to harden.

The proximal end of the lead has multiple terminal contacts defining a connector having material between the terminal contacts. The material between the terminal contacts therefore may be a combination of terminal spacer material plus epoxy or solely epoxy. Often, the lead body insulation is a softer polyurethane or silicone material than the material between the terminal contacts. The use of epoxy alone or in combination with a chosen terminal spacer material can be used to yield a desired flexibility and buckling resistance at the proximal, connector end of the lead. Such buckling resistance may be desired or necessary with certain connector systems that require a specific insertion force. For example, spring-like connectors may be used in the IPG header. Spring-like connectors require a certain insertion force to engage the connector end of a lead. If the connector end is too soft or flexible, the medical practitioner can have a difficult time inserting the connector end of the lead into the connector block of the IPG without the lead buckling.

The distal end of the lead can be any configuration. In particular the distal end of the lead may be linear or paddle shaped to provide a stimulation lead. If the lead has a linear distal end, the electrode contacts can be spaced apart from each other by placing electrode contact spacers between adjacent electrode contacts. The electrode contact spacers may be made of polyurethane or, conceivably, some other spacer materials including PEEK, polyester, polyethylene, polysulfone or silicone. Generally, however, it is desirable to keep the distal end of the lead relatively pliable and, hence, a flexible electrically insulative material such as polyurethane or silicone is preferred at the distal end. The electrode spacers may be ring shaped or ring-like in configuration. The electrode contacts may also be rings or ring-like in configuration.

If the distal end of the lead is a paddle, the paddle must generally have at least one major flat surface. Electrode contacts may be placed in various arrangements over the flat surface. The paddle itself may be made from a relatively flexible material such as polyurethane or silicone to allow the paddle to conform to tissue.

The lead may also be an extension lead having the usual proximal multiple, terminal contacts at the connector end but also having a distal end with a female connector or receptacle for accepting the proximal, connector end of a stimulation lead such as a percutaneous lead or a paddle lead as described.

The lead, whether a linear, paddle, extension or adapter lead, may optionally include a preformed lead body. The lead body is the middle portion of a lead and can be made from a relatively flexible insulative material such as silicone or polyurethane. Such a lead body may have individual conductor lumens that carry individual conductors within each conductor lumen. Each conductor may be constructed of multiple strands of smaller conductor wires. The lead body may also include a larger, stylet lumen running the length of the lead body. The stylet lumen may be configured and sized to accept the insertion of a stylet or guide to help implant and guide the lead during implantation. The stylet lumen may be centrally or axially located while the conductor lumens are placed peripherally around the axially positioned stylet lumen. The lead body, made of polyurethane or silicone, and having conductor lumens and/or a stylet lumen can be extruded using known extrusion methods.

Also discussed herein are methods of making the various embodiments of the proximal, connector portions of leads and of the leads themselves. In particular the methods are for making a lead having a connector end with terminal contacts, terminal spacers and epoxy and for a connector with terminal contacts and only epoxy without spacers. The methods of making leads includes embodiments for making linear, paddle, extension and adapter leads with the particular connector ends described.

The above and other aspects of the present invention will be more apparent from the following more particular description thereof, presented in conjunction with the following drawings wherein:

FIG. 1 shows a generalized spinal cord stimulation system with a exemplary percutaneous lead connected to an implantable pulse generator (“IPG”);

FIG. 2 shows an illustration of the percutaneous lead implanted into the epidural space of a human spinal cord;

FIG. 3A shows a side view of the distal end of a percutaneous lead.

FIG. 3B shows a side view of the proximal (connector) end of the percutaneous lead shown in FIG. 3A;

FIG. 4 shows a view of the proximal, terminal end of the lead assembly showing the terminal (connector) contacts and conductor wires that connect to each terminal (connector) contact;

FIG. 5A shows a cross-sectional view of the percutaneous lead shown in FIG. 3A at line 5A-5A;

FIG. 5B shows a cross-sectional view of the percutaneous lead shown in FIG. 5A along line 5B-5B;

FIG. 5C shows a perspective view of an embodiment of the lead body, having an axially positioned stylet lumen and peripherally surrounding smaller conductor lumens for containing conductor wires;

FIG. 6A shows a close-up, partial, longitudinal view of the lead assembly at the distal portion of the lead;

FIG. 6B depicts how polyurethane monofilament can be used to fill the voids and is incorporated as part of the distal end of the lead by applying heat;

FIG. 7 shows an illustration of an exemplary paddle lead with a plurality of terminal contacts at the proximal end and plurality of contacts on the paddle surface;

FIG. 8 shows a view of the terminal, connector end of a lead showing three terminal contacts; and

FIG. 9 shows a view of a ring shaped (or cylindrical ring-shaped) terminal contact having a slot at one end.

Corresponding reference characters indicate corresponding components throughout the several views of the drawings.

The following description is of the best mode presently contemplated for carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of describing the general principles of the invention. The scope of the invention should be determined with reference to the claims.

FIG. 1 shows a generalized stimulation system that may be used in spinal cord stimulation (SCS), as well as other stimulation applications. Such a system typically comprises an implantable pulse generator (“IPG”) 12, an optional lead extension 14, a linear or percutaneous stimulation lead 16 and an electrode array 18 that is part of the linear stimulation lead. The electrode array 18 includes a plurality of electrode contacts 17. In a percutaneous lead, the electrode contacts 17 can be arranged in an in-line electrode array 18 at the distal end of the lead 16. Other electrode array configurations can also be used. The IPG 12 generates stimulation current pulses that are applied to selected electrode contacts 17 within the electrode array 18.

The proximal end of the extension lead 14 (sometimes also referred to alternatively as a “lead extension”) can be removably connected to the IPG 12 and a distal end of the extension lead 14 can be removably connected to a proximal end of the lead 16. The electrode array 18 is formed on a distal end of the percutaneous stimulation lead 16. The in-series combination of the extension lead 14 and percutaneous lead 16 conduct the stimulation current from the IPG 12 to electrode contacts 17 of the electrode array 18. It is noted that the extension lead 14 need not always be used with the neural stimulation system 10. Instead, the extension lead 14 may optionally be used when the physical distance between the IPG 12 and the electrode array 18 requires its use or, sometimes, for the purpose of a temporary trial procedure. The IPG 12 includes a header piece or connector block 5 which has at least one opening to accept the connector end of an extension lead 14 or the proximal, connector end of lead 16. In some cases, the connector block 5 can have two openings to accept the connector ends of two stimulation leads or extension leads.

The IPG 12 contains electrical circuitry and can be powered by an internal primary (one-time-use-only) or a rechargeable battery, which through the use of electrical circuitry can output current pulses to each stimulation channel. Communication with the implanted IPG can be accomplished using an external programmer (not shown), typically through a radio-frequency (RF) link.

FIG. 2 shows a transverse, mid-sagittal view of a spinal cord and a generalized, implantable, spinal cord stimulation system. The stimulation system shown is being used as a spinal cord stimulator (SCS) system. In such an application, the percutaneous stimulation lead 16 and, more particularly, the electrode array 18 are implanted in the epidural space 20 of a patient in close proximity to the spinal cord 19. Because of the lack of space near the lead exit point 15 where the electrode lead 16 exits the spinal column, the IPG 12 may be implanted in the abdomen or above the buttocks. Use of an extension lead 14 facilitates locating the IPG 12 away from the lead exit point 15.

FIG. 3A shows the distal end of a linear or percutaneous lead 16, showing electrode contacts 17 and insulative material 61 between electrode contacts, defining the electrode array 18.

FIG. 3B shows a depiction of the proximal end of the percutaneous stimulation lead 16. This proximal lead end, may include eight, electrically conductive, terminal (or connector) contacts 40, and may also include a contact tip element 41. Collectively, the lead end, including the connector (terminal) contacts 40, will be called herein as the proximal, lead connector end 42 of the stimulating lead 16. Terminal (or connector) contact spacers 45 are placed between the terminal contacts 40. Typically the spacers 45 are an electrically insulative material.

Referring to FIGS. 3B and 4, the terminal contacts 40 may be made from a non-corrosive, electrically conductive material, e.g., platinum/iridium alloy or platinum. Contact tip 41, however, is not electrically connected to any conductor and contact tip 41 may merely serve as a hard surface for a mechanical contact securing device, such as a set screw (not shown), which may be used to secure the lead connector end 42 with the connector block of the IPG 12. Contact tip 41 is optional and does not need to be included as part of the lead. Instead, the contact tip of the lead may be of similar or the same insulation material as the remainder of the lead 16 or lead body 110 (FIG. 5C). Cylindrical ring element (“retention sleeve”) 46 is also optional and not connected to any conductor. The retention sleeve 46, which may be made of non-corrosive metal such as titanium, stainless steel or platinum/iridium alloy, may also be used to secure a set screw (not shown) that is located in the connector block 5 (shown in FIG. 2). When the set screw is screwed into the connector block 5, the end of the screw contacts the retention sleeve 46 and mechanically secures the proximal, connector end of the lead within the connector block 5 and prevents the connector end of the lead from being removed.

FIG. 4 shows a proximal lead assembly with each of the terminal (connector) contacts 40 welded to a respective one of a plurality of conductors 122. A portion of the lead body 110 is shown. The conductors 122 are inserted into individual conductor lumens in the lead body 110. Each of the eight terminal contacts 40, as shown, are connected to a conductor 122 which, in turn, are connected to a respective electrode contact 17 at the distal end of the stimulating lead 16. The connection may be a weld. The insulating material between the terminal contacts 40 and around the conductors 122 is not shown in FIG. 4 for purposes of better illustrating the connection between each conductor and its respective terminal contact. Cylindrical ring element (“retention sleeve”) 46 is optional and is not connected to any conductor. The retention sleeve 46 may be used as a contact element for a mechanical securing device such as a set screw in order to secure the percutaneous stimulation lead 16 to the IPG 12. Alternatively or, in addition, the retention sleeve 46 may function as a radiopaque element, provided that the material used for element 46 is radiopaque.

The shape of the terminal spacers 45 (FIG. 3B) can be a ring, ring-like or a short, cylindrical tube. One efficient way of manufacturing the terminal spacers 45 is to extrude or form a long tube and then cut short segments of the tube to create each terminal spacer 45. Other known methods may be used to make each terminal spacer 45. The terminal spacer 45 is therefore pre-formed before being assembled with other components of the stimulation lead 16.

The terminal spacers 45 may be made from an implantable grade polyurethane such as Pellethane® 55D thermoplastic material. Alternatively, the terminal spacers 45 may be made from polyarylether ketone or polyetherether ketone. As used herein, we will refer, collectively, to both types of ketones as “PEEK” material. In another embodiment, the terminal spacers 45 may be made from polysulfone. In yet other embodiments, the terminal spacers may be made from polyester, polyethylene or silicone.

An epoxy material may be applied between any void space within the terminal spacers 45 and terminal contacts and small voids between the terminal spacer 45 and terminal contacts 40 and, sometimes, within at least some portion of the conductor lumens (when a preformed lead body with conductor lumens is used) near the proximal end of the lead. The epoxy material should be implantable grade. In one embodiment, where the proximal end of the lead is intended to be stiffer than the middle portion of the lead, the epoxy may be an 85D (durometer hardness) material although other hardness grades of epoxy may be used to achieve a desired stiffness at the proximal end of the lead. The epoxy material may be deliberately chosen to create a proximal end of the lead which is stiff and relatively inflexible compared to the middle portion of the lead. The extra stiffness at the proximal end of the lead may be desirable in order to facilitate insertion of the proximal end of the lead into a connector header 5 that is attached to an IPG 12.

In yet another embodiment, the material separating the terminal contacts on the proximal end of the lead may not use preformed terminal spacers 45 between the terminal contacts. Instead, only epoxy is placed between the terminal contacts. Once cured, the epoxy may be a relatively hard and inflexible material compared to the other parts of the lead that employs insulation which may be made of a softer polyurethane or silicone. An epoxy that is 85D hardness material can be used to provide a stiffer connector end compared to a lead body that is made from a 55D polyurethane.

FIG. 5A shows a cross-sectional view of a lead body, for example, of FIG. 3A along line 5A-5A.

FIG. 5B shows a partial, longitudinal, cross-sectional view of the lead body along the line 5B-5B.

FIG. 5C shows a perspective view of an exemplary lead body 110 of the lead 16, excluding conductor wires. The lead body 110 is that portion of the lead insulation 112 that is between the distal electrode contact array 18 and the array of terminal (connector) contacts 40 (FIG. 4) at the proximal lead end 42. The lead body 110 may be extruded as a one-piece component. Note the central stylet lumen 114 and the surrounding eight conductor lumens 116.

FIGS. 5A and 5B show an exemplary embodiment of an insulation section 112 of the lead body 110 having eight lumens 116 containing the conductor (wires) 122, having individual strands 120. For example, fifteen or sixteen individual conductor strands 120 may be braided or bundled into a single conductor 122. Also shown is a central lumen 114 that may be used to accept an insertion stylet (not shown) within the lumen to facilitate lead implantation. The opening of the lumen occurs at the proximal end of the lead 16. The lead body 110 may be a biocompatible, insulating lead material. Preferably the lead body 110 is made from a polyurethane. In particular the material may be Pellethane® thermoplastic material, e.g. 55D, 65D, or other durometer hardness. As previously indicated for FIG. 5C, the lead body 110 shown in FIG. 5B may be extruded as one piece. It should be understood that the lead body 110 is only one possible configuration that could be used and other types of lead bodies having different configuration could be used. For example, the lead body may not have a stylet lumen, but only a single conductor lumen that contains all the conductors. The construction of the lead body does not prevent the construction of a proximal end of the lead having multiple terminal contacts separated by insulative material or materials, e.g., spacers or epoxy.

The lead has at least two terminal contacts at the proximal, connector end of the lead. There are two embodiments of materials that can be placed between the terminal contacts: (1) the first embodiment uses terminal spacers, with epoxy or another adhesive-like, electrically insulative material filling the voids or spaces within the terminal spacers and terminal contacts and between a terminal spacer and a terminal contact or (2) epoxy alone filling the separation gap between adjacent terminal contacts.

The distal end of the lead can be any type of electrode configuration that is known. For example, the distal end of the lead may be linear or percutaneous or it may be a paddle shape. The following show in more detail leads having proximal or connector ends as described in (1) and (2) above.

FIG. 3A shows a distal portion of a linear or percutaneous lead 16 that may include embodiments of the proximal lead construction as described above. The stimulating lead 16 is used to stimulate neural tissue by delivering electrical stimulus pulses through at least one of the electrode contacts 17. The electrode contacts 17 can be separated by insulative material, for example, by electrode contact spacers (“electrode spacers”) 61 that insulate the electrode contacts 17 from each other. A radiopaque marker 30 located at the distal tip of the lead 16 may be optionally included. Alternatively, the tip 30 of the lead may be the same material as the remainder of the lead insulation. The IPG 12 may be configured with a connector block 5 to permit connection to two stimulating leads, each having eight electrode contacts 17. A pair of stimulating leads 16 may be connected to an IPG 12 and an electrical circuit may be created between one electrode contact on the first lead and another electrode contact located on the second lead. The IPG 12, for example, may have sixteen independently programmable outputs that allow programming of pulse amplitude, pulse width and frequency of the pulse width. The electrode contacts 17 are to be made of a bio-compatible, electrically conductive electrode material such as platinum/iridium alloy, platinum, titanium or the like.

As an example, the linear stimulating lead 16 may have a diameter of between about 0.03 to 0.07 inches for spinal cord stimulation applications. An insertion cannula (not shown), e.g., a 14 gauge insertion needle may be used, while a 0.05 inch diameter stimulating lead is inserted within the cannula to help implant the stimulating lead 16. The stimulating lead 16 may come in a variety of lengths, e.g., 30, 50, 70 and 90 cm. A practitioner can extend the length of any of the available lead lengths by opting to use an extension lead 14 (shown in FIG. 1). The proximal male end of the extension lead 14 should be configured to be insertable into the lead connector of the IPG and the distal female end of the extension lead should be configured to accept the proximal connector end of the stimulating lead 16.

An embodiment of the percutaneous or linear stimulating lead 16 is isodiametric or substantially isodiametric, meaning that the diameter along the lead's entire length is constant or nearly constant. However, a linear lead 16 does not need to be entirely isodiametric. For example, the connector contacts 40 at the proximal end of a linear lead may be larger (oversized) or smaller in diameter compared to the remainder of the lead 16 or lead body 110 (shown in FIG. 5C). Likewise, the electrode contacts 17 may be larger (oversized) or smaller in diameter compared to the remainder of the lead 16 or lead body 110 (shown in FIG. 5C).

FIG. 6A shows a partial view of a longitudinal, cross-section at the distal end of an example linear lead. FIG. 6A shows a ring-like electrode contact 17 (which may be platinum, for example), multi-stranded conductor 122 and electrode contact spacer 61 (or an insulative material). The electrode spacer 61, which may be ring-like in configuration, may be made of polyurethane insulative material, e.g., Pellethane®. Monofilament 60, also may be made of thermoplastic Pellethane® material or other insulation material, e.g., polyester. During manufacture, the monofilament 60 may be inserted into the void spaces that are not filled by the conductor 50. A heat shrink tube 65 is also shown placed around the electrode contacts 17 and conductor 122 assembly. The heat shrink tube 65 may be PTFE (e.g., Teflon® material) or a polyester heat shrink material. The heat shrink tube is a tool that may be used during manufacturing to form the distal end of the percutaneous lead and is not part of the assembled stimulation lead.

FIG. 6B shows a two-frame, time-elapsed illustration of a partial view of the distal end of the linear lead as in FIG. 6A showing the conductor 122 connected (e.g., welded) to the electrode contact 17. The first frame (i) of FIG. 6B shows the sequence in which the monofilament 60 fills a large part of the void space 70 which space may be a conductor lumen or channel. The part of the lead assembly shown is then placed into a heat, for example, at 190 degrees Celsius for a period of 30 seconds. The heat that may be used, e.g., for a polyurethane material (e.g., Pellethane™ polyurethane), may range from about 140 to 250 degrees Celsius for a period of about between 15 to 120 seconds. However, importantly, the heat applied to the spacer and monofilament material, should be just below the melting temperature of the material. At this just-below-melting temperature, the electrode spacer 61 and monofilament 60 will reflow and thermally fuse together as shown in the second frame (ii). The spacer 61 and the monofilament 60 may be exactly the same material with the same melting temperature in order to facilitate thermal fusion. For example, the material may be the same implantable grade polyurethane such as Pellethane 55D or 75D. This illustrates one way the distal end of percutaneous lead can be manufactured.

The monofilament 60 may be of a different material than the electrode spacer 61 to alter the mechanical characteristic of the final lead assembly. The monofilament and spacer may have different melting points or very close melting points. The monofilament and spacers may be the same type of material but with different formulations, e.g., to provide different hardness. For example, the monofilament may be a 55D (durometer hardness) material and the spacer may be a 75D material. The predetermined temperature chosen to heat both the monofilament and spacers should cause at least one of the materials used to thermally reflow or, alternatively, to melt. In some cases, the temperature may be chosen that one material melts while the other material thermally reflows. FIGS. 6A and 6B show the distal end of the linear lead with monofilament filling a distal portion of the lead, including a part of the distal portion of the conductor lumens.

The terminal spacers 45 at the proximal end of the lead (shown in FIG. 3B) can be placed between adjacent terminal (connector) contacts 40. In one embodiment of the invention, the terminal spacers 45 may be oversized before assembly—that is, the terminal spacers, which may be made from polyurethane, PEEK, polysulfone, polyester, polyethylene or in some cases, silicone, may have an initial diameter that is larger than the final lead diameter. The terminal spacers may be ground, for instance by using centerless grinding, to a diameter that is the same as the terminal contacts.

FIG. 7 shows an example paddle lead 16′ that includes a terminal or connector end having (a) terminal spacers 45 with epoxy applied within terminal spacers and terminal contacts 40, as well as between the terminal spacers and terminal contacts or (b) epoxy only between the terminal contacts 40.

The paddle lead 16′ has a paddle portion 80 at the distal end of the lead. The paddle portion 80 has at least one flat surface 81 that has multiple electrode contacts 17′ placed upon it. The paddle lead 16′ shown has eight electrode contacts 17′. FIG. 7 also shows the terminal or proximal end of the lead. The terminal or proximal end of the lead has at least two terminal contacts 40. Adjacent terminal contacts 40 are separated by an electrically insulating material 45. This insulating material between the terminal contacts can be (1) terminal spacers that is an insulative material, e.g., epoxy, that is different from the lead body 110, which may be polyurethane or silicone; or (2) solely epoxy. The proximal connector end therefore can be used with many types of configurations at the distal end of the lead.

FIG. 8 shows a close-up view of the proximal, connector end of a lead. This particular example only shows four terminal contacts 40 and three oversized terminal spacers 45 between adjacent terminal contacts. The oversized terminal spacers 45 can be ground down on the outside surface to match the diameter of the terminal contacts 40 in the final lead assembly. At the terminal end of the lead, the conductors 122, as shown in FIG. 4, are each individually welded to the terminal contacts 40. As can be seen from FIGS. 4 and 8, there is a space created inside the ring-shaped or ring-like terminal contacts because the conductors 122 do not occupy all the space within the terminal contacts and the ring-shaped or ring-like terminal spacers 45. Before proximal tip 41 is attached or glued onto the lead, FIG. 8 shows that there is an opening 90 at the most proximal terminal contact 40. This opening may be used during manufacturing to inject epoxy or other adhesive-like, insulating material into the space within or inside the ring-shaped terminal contacts or terminal spacers. The injected material, e.g., 85D epoxy (e.g., Hysol® epoxy), will fill the void inside the proximal end of the lead formed by terminal spacers and terminal contacts. In addition, some of the epoxy may fill any small void spaces 48 between adjacent terminal contacts and terminal spacers. If a lead body, having multiple lumens, such as shown in FIGS. 5A, 5B and 5C, is used, some of the injected epoxy can even migrate to the proximal portion of the lead body filling a portion of the lumens 116. The injection of the epoxy, can contribute to the ultimate stiffness and buckling strength of the proximal, connector end of the lead. In addition, the choice of the terminal spacer material can also contribute to ultimate stiffness and buckling strength of the proximal, connector end of the lead.

FIG. 9 shows one embodiment of the terminal contact 40 having a slot 85 cut out from the edge of the contact 40. This slot can be useful for welding the terminal contact to a conductor. The slot can be used to draw the end of the conductor into the slot while the conductor end is welded to the terminal contact. Similarly, the electrode contact at the distal end of a linear lead can also employ such a slot in a ring-like shaped electrode contact.

The following illustrates various embodiments of leads.

The lead has a plurality of connector (terminal) contacts, e.g., eight terminal contacts at the proximal end of the lead. Between the terminal contacts are spacers. The terminal contacts are shaped as rings or configured to be ring-like. In particular, the terminal contacts may be cylindrical rings. The terminal spacers are also formed into rings or configured to be ring-like. In particular they may also be cylindrical rings. The terminal spacers may be made from a number of materials. For example, the terminal spacers may be made from polyurethane, e.g., Pellethane™ 55D polyurethane. Other suitable materials include polyetherether ketone or polyarylether ketone (collectively, PEEK), polysulfone, polyester, silicone, and polyethylene. The choice of terminal spacer materials may be determined based on desired stiffness at the proximal end of the lead. For example PEEK and Polysulfone material may be harder than a 55D polyurethane. In addition, epoxy may be applied, e.g., injected, into void space within the terminal contact and terminal spacers and also applied in the small void spaces between a terminal contact and a terminal spacer. 85D Epoxy is also a harder and less flexible material than 55D.

The lead is linear and includes a proximal portion of the lead which is described in Example 1. Thus, the proximal end of the lead has a terminal spacer that is made from the group of materials: PEEK, polysulfone, polyester, silicone, and polyethylene. Epoxy may be applied, e.g., injected, in void spaces within the terminal spacers and terminal contacts and between a terminal spacer and an adjacent terminal contact. The distal end of the lead is linear and includes a plurality of electrode contacts, preferably formed into a ring or ring-like configuration, and more preferably a cylindrical ring. The distal end of the lead can optionally use electrode contact spacers, e.g., of polyurethane.

The lead is not isodiametric, e.g., a paddle having at least one major flat surface and the proximal end of the lead includes terminal spacers between terminal contacts. The flat portion of the paddle includes a plurality of electrode contacts located on the flat portion of the paddle. The proximal or connector portion of the lead, however, is identical to the lead described in Example 1. Epoxy may be applied within the terminal spacers and terminal contacts and also in small voids spaces between a terminal spacer and a terminal contact.

The lead has a plurality of terminal contacts. The proximal end of the lead uses epoxy placed between the adjacent terminal contacts to form the connector.

As described in Example 4, the proximal end of the lead uses epoxy placed between adjacent terminal contacts to form the connector. The terminal contact are preferably rings or ring-like. No terminal spacer is used. The distal end of the lead is linear and includes a plurality of electrode contacts, preferably formed into a ring or ring-like configuration and, more preferably, a cylindrical ring.

As described in Example 4, the proximal end of the lead uses epoxy between adjacent terminal contacts. The distal end of the lead has a paddle having at least one major flat surface. The flat surface of the paddle includes a plurality of electrode contacts.

A lead extension 14 (FIGS. 1 and 2) can have a proximal connector end with multiple, terminal contacts and epoxy only separating the terminal contacts as described in Example 4. The extension lead has a female connector or receptacle at the distal end of the extension lead. The female connector or receptacle may be configured to accommodate the proximal end of a stimulation lead, e.g., a linear or paddle lead as described in Examples 1-6 having an identical proximal connector configuration as the extension lead itself. Or, alternatively, the female connector or receptable may be configured to accept the proximal end of a stimulation lead, which proximal end of the stimulation lead is not compatible with the connector block 5 of IPG 12. For example, different manufacturers use different connectors at the ends of their stimulation leads and are therefore not compatible with IPG connector blocks of another manufacturer. The extension lead can be made to connect the IPG to the stimulation lead and hence “adapt” the stimulation lead to the IPG. Such an extension lead is actually referred to as a “lead adapter” because it adapts a stimulation lead to a normally incompatible IPG.

A lead extension 14 (FIGS. 1 and 2) can have a connector with a multiple terminal contacts at the proximal end. As described in Example 1, the terminal contacts 45 may be separated by terminal spacers 40 made from the following body implantable materials as previously discussed: PEEK, polysulfone, polyester, silicone, and polyethylene. A second insulative, adhesive-like material, e.g., epoxy may be used to fill voids within the terminal contacts and terminals spacers not filled by conductor wire, and also voids within the terminal contact and terminal spacer and voids between an adjacent terminal contact and a terminal spacer. The female end of the extension lead can be used to accommodate a stimulation lead, e.g., a linear or paddle lead having an identical proximal connector configuration as the extension lead or, alternatively, a stimulation lead that has a connector configuration that cannot directly fit into and hence incompatible with the connector block 5 of the IPG 12. Such an extension lead is actually referred to as a “lead adapter” because it adapts a stimulation lead to a normally incompatible IPG.

Methods of Making Stimulation Leads, Extension Leads or Lead Adapters

The following steps illustrates specific steps for making a proximal connector end of a stimulation lead, an extension lead or a lead adapter and additional steps for making a stimulation lead, an extension lead or a lead adapter. Embodiments of the method can include one or more of the following steps (although not necessarily in the order presented).

An embodiment of the method of manufacturing a lead with a terminal, proximal end and a distal end and an insulative covering is disclosed. The method includes: placing a plurality of conductive terminal contacts at the terminal, proximal end of the stimulation lead; placing at least one electrode contact on the distal end of the lead; connecting at least one conductor wire to one of the conductive terminal contacts; placing a terminal spacer between a pair of adjacent conductive terminal contacts; and applying epoxy in any voids within the at least one spacer and terminal contact and between at least one spacer and terminal contact.

In an alternative method of manufacturing a lead, the stimulation lead has a terminal end and a distal end and an insulative covering. The method includes: providing a lead having a plurality of conductor lumens; placing a plurality of conductive terminal contacts at the distal end of the stimulation lead; connecting at least one conductor wire to one of the conductive terminal contacts; and placing epoxy between two terminal contacts.

As further steps to the method of manufacturing a lead, specific types of leads may be manufactured. For example, a paddle stimulation lead may be made by connecting a paddle with electrode contacts at the distal part of the lead. Alternatively, a linear lead may be produced by connecting a linear distal portion to the lead. Still yet, an extension lead may be produced by connecting a female receptacle connector end at the distal end of the lead, the female connector configured to accept the proximal end of a stimulation lead. Still further, an extension that is a lead adapter may be produced by connecting a female connector end to the lead, the female connector end having a configuration that is compatible and accepts the proximal end of a lead which is not compatible with the IPG connector.

A more detailed embodiment of making a lead having terminal spacers and epoxy in the void spaces within the spacers and terminal contacts and voids between spacers and terminal contacts is as follows: a braided or bundled, insulated, multi-filament conductor, e.g., having between 2 and 200 filaments, can be ablated of insulation at one end to expose the conductor; the exposed end of the conductor can be welded to a terminal (proximal) contact (located on the distal end lead assembly); terminal spacers (which may be made of polyurethane, PEEK, Polysulfone, polyester, polyethylene or silicone) may be placed between the terminal contacts; if a lead body with a multiple conductor lumens is used, each end of the conductor cable can be inserted through the corresponding conductor lumens in the lead body; the terminal spacers can be placed between each ring-like terminal contact at the distal end of the lead assembly; the spacers 61 may be “oversized”, meaning that they may have a diameter greater than the lead body 110 and in addition, the diameter of the terminal contacts 17 may be oversized compared to the diameter of the lead body 110; the distal end of each conductor cable can be welded to the ring or ring-shaped (ring-like) terminal contact; and epoxy may injected into the middle opening of the most proximal terminal spacer (or in some cases the most proximal terminal contact). This epoxy will fill the void space with the terminal spacers and terminal contacts and some of the epoxy may be forced through the void spaces between a terminal spacer and terminal contact and thereby fill those void spaces. The steps described above can be performed in a different sequence and some steps may be optionally left out.

A detailed embodiment of making a lead having only epoxy between terminal contacts may be as follows: a braided or bundled, insulated, multi-filament conductor, e.g., having between 2 and 200 filaments, can be ablated of insulation at one end to expose the conductor; the exposed end of the conductor can be welded to a terminal (proximal) contact (located on the distal end lead assembly); if a lead body with a multiple conductor lumens is used, each end of the conductor cable can be inserted through the corresponding conductor lumens in the lead body; the distal end of each conductor cable can be welded to the ring-shaped or ring-like terminal contact; the terminal contacts may be held in a mold which keeps a prescribed space between the next terminal contact; and epoxy may applied, e.g., injected into the open areas between the terminal contacts to fill those spaces. The epoxy is, in a sense, casted over the proximal end and conductor wires. After the epoxy has cured, the proximal lead end may be ground, e.g., with centerless grinding, to a prescribed diameter at this point or later in the manufacturing method. The steps described above can be performed in a different sequence and some steps may be optionally left out.

The proximal, connector end of the lead may be assembled first and then the distal end may also be assembled. (It is also possible that the order can be reversed and the distal end is assembled first.) A specific example of a method of making the distal end of a linear (percutaneous) lead was described in detail in the U.S. patent application Ser. No. 11/329,907, the parent application to the present application. This method includes using a polyurethane monofilament placed inside void spaced as shown in FIG. 6A and inside any empty conductor lumens 116 at the distal end of the lead; a heat shrink tube or wrap, preferably, made from PTFE (Teflon) or polyester, can be placed over the distal end of the lead assembly and over the electrode array; this distal end can be placed into a high temperature block, e.g., between about 140-250 degrees Celsius for a period of about 30 to 120 seconds; the distal assembly can be removed from the heat and the shrink tube or wrap can be removed; and optionally, the distal tip of the lead can be formed using an RF welder.

Post processing of the linear lead may not be required if the diameter of the terminal spacers, the terminal contacts, the electrode spacers and the electrode contacts are the same as the lead body. However, if any of these parts are oversized, a centerless grinding process may be used, if desired, to remove excess outer material of the intermediate lead assembly that has the proximal end and distal end assembled.

It is also possible to produce other types of leads. For example, once the proximal end of the lead is made, either with terminal spacers and epoxy or solely with epoxy between the terminal contacts, the method of manufacturing the lead can proceed to making a particular configuration of the distal part of the lead, i.e., (a) making a paddle with multiple contacts or (b) making a female connector of an extension lead or lead adapter. As will be understood by those skilled in the art, known methods of making these particular distal parts of leads and lead extensions may be used.

The above methods describe how a lead may be made having a proximal end made with epoxy between the terminal contacts or, alternatively, a lead having a proximal end with terminal spacers and a second material such as epoxy. The terminal spacers can be made from various materials: polyurethane, PEEK, polysulfone, polyethylene, polyester or silicone.

In summary, in some embodiments the lead will be a linear or percutaneous lead. Such a lead can have an epoxy terminal at the proximal portion of the lead. In other embodiments, the percutaneous lead will employ spacers between the terminal contacts.

In other embodiments the lead is not be linear, i.e., it may be a paddle type lead, which is not isodiametric. The lead will also have a plurality of terminal contacts and a plurality of electrode contacts at the paddle, distal end of the lead. The proximal, terminal end of the lead can either have material between the terminal contacts or, alternatively, the proximal end can employ terminal spacers. Such spacers can be the various materials listed: polyurethane, PEEK, polysulfone, polyethylene, polyester or silicone.

In yet other embodiments, the lead is an extension lead that may have a proximal end that uses terminal spacers and epoxy at the terminal end or solely epoxy between two terminal contacts. More particularly, the extension lead may be an adapter lead.

Although the lead and method of making the lead are described in the context of a spinal cord stimulation, e.g., percutaneous or linear leads, paddle leads, or extension leads, it will be understood by those skilled in the art that the same lead, albeit with appropriate dimensions for a particular application, may be used for other treatment applications such as deep brain stimulation and peripheral nerve stimulation.

While the invention herein disclosed has been described by means of specific embodiments and applications thereof, numerous modifications and variations could be made thereto by those skilled in the art without departing from the scope of the invention set forth in the claims.

Pianca, Anne M, Kuzma, Janusz A, Girgis, Milad, Walter, Jeryle L

Patent Priority Assignee Title
10010715, Dec 04 2013 Boston Scientific Neuromodulation Corporation Systems and methods for delivering therapy to the dorsal horn of a patient
10016593, Dec 04 2012 Boston Scientific Neuromodulation Corporation Implantable medical device having electromagnetic interference filter device to reduce pocket tissue heating
10016594, Jun 28 2011 Boston Scientific Neuromodulation Corporation System and method for using impedance to determine proximity and orientation of segmented electrodes
10016602, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
10016605, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
10016610, Aug 28 2012 Boston Scientific Neuromodulation Corporation Point-and-click programming for deep brain stimulation using real-time monopolar review trendlines
10029102, Jun 06 2013 Boston Scientific Neuromodulation Corporation System and method for delivering modulated sub-threshold therapy to a patient
10067659, Aug 24 2015 Boston Scientific Neuromodulation Corporation Systems and methods for determining orientation of an implanted lead
10071249, Oct 09 2015 Boston Scientific Neuromodulation Corporation System and methods for clinical effects mapping for directional stimulation leads
10080896, Mar 15 2013 CIRTEC MEDICAL CORP Implantable pulse generator that generates spinal cord stimulation signals for a human body
10112050, Jun 28 2013 Boston Scientific Neuromodulation Corporation Electrode selection for sub-threshold modulation therapy
10118036, May 28 2015 Boston Scientific Neuromodulation Corporation Neuromodulation using stochastically-modulated stimulation parameters
10118040, Mar 08 2013 Boston Scientific Neuromodulation Corporation Neuromodulation using modulated pulse train
10149977, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
10159837, Sep 19 2012 Boston Scientific Neuromodulation Corporation Preferential therapeutic modulation without patient-perceived paresthesia
10183166, Jun 21 2013 Boston Scientific Neuromodulation Corporation Systems and method for automatically detecting an MRI environment for patient implanted with medical device
10195429, Aug 02 2017 LUNGPACER MEDICAL INC Systems and methods for intravascular catheter positioning and/or nerve stimulation
10207109, Feb 22 2013 Boston Scientific Neuromodulation Corporation System for combining electrical waveforms into a combined electrical waveform
10213229, Dec 10 2012 Nevro Corp. Lead insertion devices and associated systems and methods
10213608, Jul 03 2014 Boston Scientific Neuromodulation Corporation Neurostimulation system with flexible patterning and waveforms
10226628, Mar 15 2013 CIRTEC MEDICAL CORP Implantable pulse generator that generates spinal cord stimulation signals for a human body
10258797, May 28 2015 Boston Scientific Neuromodulation Corporation Neuromodulation using stochastically-modulated stimulation parameters
10258799, Apr 04 2013 Boston Scientific Neuromodulation Corporation Management of stimulation safety limits in a neurostimulation system
10265526, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
10265528, Jul 30 2014 Boston Scientific Neuromodulation Corporation Systems and methods for electrical stimulation-related patient population volume analysis and use
10265531, Sep 01 2015 Boston Scientific Neuromodulation Corporation Detection of lead orientation
10265532, Aug 28 2012 Boston Scientific Neuromodulation Corporation Point-and-click programming for deep brain stimulation using real-time monopolar review trendlines
10272240, Apr 03 2017 PRESIDIO MEDICAL, INC Systems and methods for direct current nerve conduction block
10272247, Jul 30 2014 Boston Scientific Neuromodulation Corporation Systems and methods for stimulation-related volume analysis, creation, and sharing with integrated surgical planning and stimulation programming
10279183, Sep 30 2010 Nevro Corp. Systems and methods for detecting intrathecal penetration
10293164, May 26 2017 LUNGPACER MEDICAL INC Apparatus and methods for assisted breathing by transvascular nerve stimulation
10300278, Dec 12 2013 Boston Scientific Neuromodulation Corporation Systems and methods for programming a neuromodulation system
10307595, Aug 29 2013 Boston Scientific Neuromodulation Corporation System and method of adjusting the compliance voltage in a neuromodulation device
10322285, Jul 07 2004 Cleveland Clinic Foundation Method and device for displaying predicted volume of influence
10328265, Sep 23 2014 Boston Scientific Neuromodulation Corporation Systems and methods for receiving user-provided selection of electrode lists
10335597, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
10335601, Jul 30 2015 Boston Scientific Neuromodulation Corporation User interface for custom patterned electrical stimulation
10342979, Sep 23 2014 Boston Scientific Neuromodulation Corporation Sub-perception modulation responsive to patient input
10350404, Sep 02 2016 Boston Scientific Neuromodulation Corporation Systems and methods for visualizing and directing stimulation of neural elements
10357652, Jun 28 2011 Boston Scientific Neuromodulation Corporation System and method for using impedance to determine proximity and orientation of segmented electrodes
10357657, Oct 07 2014 Boston Scientific Neuromodulation Corporation Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters
10360511, Nov 28 2005 The Cleveland Clinic Foundation System and method to estimate region of tissue activation
10369363, Jul 24 2014 Boston Scientific Neuromodulation Corporation Enhanced dorsal horn stimulation using multiple electrical fields
10391314, Jan 21 2014 LUNGPACER MEDICAL, INC Systems and related methods for optimization of multi-electrode nerve pacing
10391315, Sep 23 2014 Boston Scientific Neuromodulation Corporation Neuromodulation with burst stimulation
10398900, Jun 28 2013 Boston Scientific Neuromodulation Corporation Electrode selection for sub-threshold modulation therapy
10406367, Jun 21 2012 Lungpacer Medical Inc. Transvascular diaphragm pacing system and methods of use
10413730, Mar 15 2013 CIRTEC MEDICAL CORP Implantable pulse generator that generates spinal cord stimulation signals for a human body
10420938, Dec 04 2013 Boston Scientific Neuromodulation Corporation Systems and methods for delivering therapy to the dorsal horn of a patient
10434302, Feb 11 2008 Intelect Medical, Inc. Directional electrode devices with locating features
10441781, Nov 23 2016 Boston Scientific Neuromodulation Corporation Systems and methods for programming neuromodulation waveform
10441800, Jun 29 2015 Boston Scientific Neuromodulation Corporation Systems and methods for selecting stimulation parameters by targeting and steering
10449360, Sep 15 2014 Boston Scientific Neuromodulation Corporation Graphical user interface for programming neurostimulation pulse patterns
10456584, Sep 15 2015 Boston Scientific Neuromodulation Corporation User interface for neuromodulation lead
10456586, Oct 15 2015 Boston Scientific Neuromodulation Corporation User interface for neurostimulation waveform composition
10471260, Sep 23 2014 Boston Scientific Neuromodulation Corporation Method and apparatus for calibrating dorsal horn stimulation using sensors
10493276, Sep 23 2014 Boston Scientific Neuromodulation Corporation Neuromodulation specific to objective function of modulation field for targeted tissue
10507328, Mar 08 2013 Boston Scientific Neuromodulation Corporation Neuromodulation using modulated pulse train
10512772, Mar 05 2012 LUNGPACER MEDICAL, INC Transvascular nerve stimulation apparatus and methods
10512778, Feb 05 2014 Boston Scientific Neuromodulation Corporation System and method for delivering modulated sub-threshold therapy to a patient
10525257, Oct 14 2016 Boston Scientific Neuromodulation Corporation Orientation marker for implantable leads and leads, systems, and methods utilizing the orientation marker
10525266, Sep 23 2014 Boston Scientific Neuromodulation Corporation Perception calibration of neural tissue using field troll
10537740, Nov 02 2009 Boston Scientific Neuromodulation Corporation Charge recovery bi-phasic control for tissue stimulation
10561843, Jan 29 2007 LUNGPACER MEDICAL INC Transvascular nerve stimulation apparatus and methods
10561844, Jun 21 2012 Lungpacer Medical Inc. Diaphragm pacing systems and methods of use
10583291, Mar 15 2013 CIRTEC MEDICAL CORP Implantable pulse generator that generates spinal cord stimulation signals for a human body
10589097, Jun 21 2012 Lungpacer Medical Inc. Transvascular diaphragm pacing systems and methods of use
10589104, Jan 10 2017 Boston Scientific Neuromodulation Corporation Systems and methods for creating stimulation programs based on user-defined areas or volumes
10603485, Nov 28 2016 Boston Scientific Neuromodulation Corporation Features in increased surface area on neuromodulation leads
10603498, Oct 14 2016 Boston Scientific Neuromodulation Corporation Systems and methods for closed-loop determination of stimulation parameter settings for an electrical simulation system
10610688, Sep 27 2016 Boston Scientific Neuromodulation Corporation Systems and methods for closed-loop pain management
10617871, Oct 30 2013 Boston Scientific Neuromodulation Corporation Spinal cord stimulation accounting for different entry angles of root fibers
10617872, Nov 23 2016 Boston Scientific Neuromodulation Corporation Systems and methods for programming neuromodulation therapy
10625082, Mar 15 2017 Boston Scientific Neuromodulation Corporation Visualization of deep brain stimulation efficacy
10631776, Jan 11 2017 Boston Scientific Neuromodulation Corporation Pain management based on respiration-mediated heart rates
10631777, Jan 11 2017 Boston Scientific Neuromodulation Corporation Pain management based on functional measurements
10631937, Apr 14 2017 Boston Scientific Neuromodulation Corporation Systems and methods for determining orientation of an implanted electrical stimulation lead
10667747, Oct 25 2016 Boston Scientific Neuromodulation Corporation Method and apparatus for pain control using baroreflex sensitivity during posture change
10668293, Mar 16 2012 Boston Scientific Neuromodulation Corporation System and method for estimating location and depth of stimulation leads
10675469, Jan 11 2017 Boston Scientific Neuromodulation Corporation Pain management based on brain activity monitoring
10709893, Oct 28 2010 Boston Scientific Neuromodulation Corporation System and method for providing fluid real-time visualization of region of tissue activation
10716505, Jul 14 2017 Boston Scientific Neuromodulation Corporation Systems and methods for estimating clinical effects of electrical stimulation
10716942, Apr 25 2016 Boston Scientific Neuromodulation Corporation System and methods for directional steering of electrical stimulation
10729905, Jan 11 2017 Boston Scientific Neuromodulation Corporation Pain management based on muscle tension measurements
10750994, Sep 27 2016 Boston Scientific Neuromodulation Corporation Method and apparatus for pain management using objective pain measure
10765867, Jan 29 2007 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
10776456, Jun 24 2016 Boston Scientific Neuromodulation Corporation Systems and methods for visual analytics of clinical effects
10780274, Aug 22 2016 Boston Scientific Neuromodulation Corporation Systems and methods for delivering spinal cord stimulation therapy
10780282, Sep 20 2016 Boston Scientific Neuromodulation Corporation Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters
10780283, May 26 2015 Boston Scientific Neuromodulation Corporation Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation
10792499, Jan 29 2007 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
10792501, Jan 03 2017 Boston Scientific Neuromodulation Corporation Systems and methods for selecting MRI-compatible stimulation parameters
10810614, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
10864373, Dec 15 2015 Case Western Reserve University Systems for treatment of a neurological disorder using electrical nerve conduction block
10864374, Jan 29 2007 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
10898718, Jul 18 2017 Boston Scientific Neuromodulation Corporation Sensor-based pain management systems and methods
10926087, Aug 02 2017 Lungpacer Medical Inc. Systems and methods for intravascular catheter positioning and/or nerve stimulation
10926091, Jan 11 2017 Boston Scientific Neuromodulation Corporation Pain management based on emotional expression measurements
10934026, Oct 19 2015 AEROJET ROCKETDYNE, INC Propulsion system with differential throttling of electric thrusters
10940308, Aug 04 2017 LUNGPACER MEDICAL INC Systems and methods for trans-esophageal sympathetic ganglion recruitment
10940314, May 28 2015 Boston Scientific Neuromodulation Corporation Neuromodulation using stochastically-modulated stimulation parameters
10940317, Aug 29 2013 Boston Scientific Neuromodulation Corporation System and method of adjusting the compliance voltage in a neuromodulation device
10946201, Aug 28 2012 Boston Scientific Neuromodulation Corporation Point-and-click programming for deep brain stimulation using real-time monopolar review trendlines
10960210, Feb 10 2017 Boston Scientific Neuromodulation Corporation Method and apparatus for pain management with sleep detection
10960212, Apr 04 2013 Boston Scientific Neuromodulation Corporation Management of stimulation safety limits in a neurostimulation system
10960214, Aug 15 2017 Boston Scientific Neuromodulation Corporation Systems and methods for controlling electrical stimulation using multiple stimulation fields
10980999, Mar 09 2017 Nevro Corp Paddle leads and delivery tools, and associated systems and methods
10981013, Aug 27 2009 The Cleveland Clinic Foundation System and method to estimate region of tissue activation
10987511, Nov 08 2018 Lungpacer Medical Inc. Stimulation systems and related user interfaces
11027126, Apr 03 2017 Presidio Medical, Inc. Systems and methods for direct current nerve conduction block
11027130, Jan 29 2007 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
11033734, Jun 15 2012 Case Western Reserve University Treatment of pain using electrical nerve conduction block
11033748, Jul 03 2014 Boston Scientific Neuromodulation Corporation Neurostimulation system with flexible patterning and waveforms
11040206, Jun 06 2013 Boston Scientific Neuromodulation Corporation System and method for delivering sub-threshold and super-threshold therapy to a patient
11064898, Jun 28 2011 Boston Scientific Neuromodulation Corporation System and method for using impedance to determine proximity and orientation of segmented electrodes
11071868, Jul 30 2015 Boston Scientific Neuromodulation Corporation User interface for custom patterned electrical stimulation
11089997, Jan 11 2017 Boston Scientific Neuromodulation Corporation Patient-specific calibration of pain quantification
11090489, Aug 02 2017 Lungpacer Medical, Inc. Systems and methods for intravascular catheter positioning and/or nerve stimulation
11103280, Dec 10 2012 Nevro Corp. Lead insertion devices and associated systems and methods
11110280, Jun 29 2015 Boston Scientific Neuromodulation Corporation Systems and methods for selecting stimulation parameters by targeting and steering
11160981, Jun 29 2015 Boston Scientific Neuromodulation Corporation Systems and methods for selecting stimulation parameters based on stimulation target region, effects, or side effects
11191954, Nov 23 2016 Boston Scientific Neuromodulation Corporation Systems and methods for programming neuromodulation waveform
11202601, Dec 01 2016 Cardiac Pacemakers, Inc. Methods and apparatus for monitoring epilepsy
11202913, Oct 07 2014 Boston Scientific Neuromodulation Corporation Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters
11224750, Mar 08 2013 Boston Scientific Neuromodulation Corporation Neuromodulation using modulated pulse train
11235155, Sep 15 2014 Boston Scientific Neuromodulation Corporation Graphical user interface for programming neurostimulation pulse patterns
11285329, Apr 27 2018 Boston Scientific Neuromodulation Corporation Systems and methods for visualizing and programming electrical stimulation
11298550, Sep 15 2015 Boston Scientific Neuromodulation Corporation User interface for neuromodulation lead
11298553, Apr 27 2018 Boston Scientific Neuromodulation Corporation Multi-mode electrical stimulation systems and methods of making and using
11311726, Mar 15 2013 Boston Scientific Neuromodulation Corporation Neuromodulation system and method for transitioning between programming modes
11311730, Jan 21 2014 Lungpacer Medical Inc. Systems and related methods for optimization of multi-electrode nerve pacing
11318300, Nov 07 2016 Case Western Reserve University Treatment of pain using electrical nerve conduction block
11324959, May 27 2011 Boston Scientific Neuromodulation Corporation Collection of clinical data for graphical representation and analysis
11331487, Oct 15 2015 Boston Scientific Neuromodulation Corporation User interface for neurostimulation waveform composition
11337646, Oct 25 2016 Boston Scientific Neuromodulation Corporation Method and apparatus for pain control using baroreflex sensitivity during posture change
11357979, May 16 2019 LUNGPACER MEDICAL INC Systems and methods for sensing and stimulation
11357985, Jun 21 2012 Lungpacer Medical Inc. Transvascular diaphragm pacing systems and methods of use
11357986, Apr 03 2017 Boston Scientific Neuromodulation Corporation Systems and methods for estimating a volume of activation using a compressed database of threshold values
11369787, Mar 05 2012 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
11382531, Sep 30 2010 Nevro Corp. Systems and methods for positioning implanted devices in a patient
11395625, Jan 11 2017 Boston Scientific Neuromodulation Corporation Pain management based on functional measurements
11420045, Mar 29 2018 Nevro Corp Leads having sidewall openings, and associated systems and methods
11439827, Jul 18 2017 Boston Scientific Neuromodulation Corporation Sensor-based pain management systems and methods
11446499, Sep 27 2016 Boston Scientific Neuromodulation Corporation Systems and methods for closed-loop pain management
11452871, Jul 07 2004 Cleveland Clinic Foundation Method and device for displaying predicted volume of influence
11504527, Jun 15 2012 Case Western Reserve University Therapy delivery devices and methods for non-damaging neural tissue conduction block
11524163, Jul 26 2013 Boston Scientific Neuromodulation Corporation Systems and methods of providing modulation therapy without patient-perception of stimulation
11541240, Jan 11 2017 Boston Scientific Neuromodulation Corporation Pain management based on brain activity monitoring
11571577, Jan 11 2017 Boston Scientific Neuromodulation Corporation Pain management based on emotional expression measurements
11583684, Apr 27 2018 Boston Scientific Neuromodulation Corporation Systems and methods for visualizing and programming electrical stimulation
11590350, Aug 22 2016 Boston Scientific Neuromodulation Corporation Systems and methods for delivering spinal cord stimulation therapy
11602635, Jul 30 2014 Boston Scientific Neuromodulation Corporation Systems and methods for stimulation-related volume analysis of therapeutic effects and other clinical indications
11607551, Jul 30 2015 Boston Scientific Neuromodulation Corporation User interface for custom patterned electrical stimulation
11633608, Aug 28 2012 Boston Scientific Neuromodulation Corporation Point-and-click programming for deep brain stimulation using real-time monopolar review trendlines
11648403, Apr 04 2013 Boston Scientific Neuromodulation Corporation Management of stimulation safety limits in a neurostimulation system
11684779, May 28 2015 Boston Scientific Neuromodulation Corporation Neuromodulation using stochastically-modulated stimulation parameters
11691014, Feb 10 2017 Boston Scientific Neuromodulation Corporation Method and apparatus for pain management with sleep detection
11704688, Mar 15 2013 CIRTEC MEDICAL CORP. Spinal cord stimulator system
11707619, Nov 22 2013 Lungpacer Medical Inc. Apparatus and methods for assisted breathing by transvascular nerve stimulation
11717673, Nov 08 2018 Lungpacer Medical Inc. Stimulation systems and related user interfaces
11730964, Nov 24 2019 PRESIDIO MEDICAL, INC Pulse generation and stimulation engine systems
11751804, Sep 27 2016 Boston Scientific Neuromodulation Corporation Method and apparatus for pain management using objective pain measure
11752329, Jul 01 2018 PRESIDIO MEDICAL, INC Systems and methods for nerve conduction block
11752348, Oct 14 2016 Boston Scientific Neuromodulation Corporation Systems and methods for closed-loop determination of stimulation parameter settings for an electrical simulation system
11759631, Mar 09 2017 Nevro Corp Paddle leads and delivery tools, and associated systems and methods
11771900, Jun 12 2019 LUNGPACER MEDICAL INC Circuitry for medical stimulation systems
11779762, Dec 15 2015 Case Western Reserve University Systems for treatment of a neurological disorder using electrical nerve conduction block
11806534, Jul 30 2014 Boston Scientific Neuromodulation Corporation Systems and methods for stimulation-related biological circuit element analysis and use
11813459, Feb 20 2018 PRESIDIO MEDICAL, INC Methods and systems for nerve conduction block
11857794, Jan 11 2017 Boston Scientific Neuromodulation Corporation Pain management based on brain activity monitoring
11872394, Jun 15 2012 CASE WESTERN RESERVE UNIVERAITY; NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT Treatment of pain using electrical nerve conduction block
11883647, Jan 11 2005 Boston Scientific Neuromodulation Corporation Electrode array assembly and method of making same
11883658, Jun 30 2017 Lungpacer Medical Inc. Devices and methods for prevention, moderation, and/or treatment of cognitive injury
11883664, Sep 27 2016 Boston Scientific Neuromodulation Corporation Systems and methods for closed-loop pain management
11890462, Nov 08 2018 LUNGPACER MEDICAL INC Stimulation systems and related user interfaces
11890470, Oct 15 2015 Boston Scientific Neuromodulation Corporation User interface for neurostimulation waveform composition
11904168, Sep 23 2014 Boston Scientific Neuromodulation Corporation Neuromodulation calibration based on health-related parameter
8688233, Jun 23 2011 Boston Scientific Neuromodulation Corporation System and method for spinal cord stimulation to treat motor disorders
8700165, Jul 16 2010 Boston Scientific Neuromodulation Corporation System and method for estimating lead configuration from neighboring relationship between electrodes
8706240, Dec 09 2011 Boston Scientific Neuromodulation Corporation Method for direct modulation of the spinothalamic tract
8750986, Jul 16 2010 Boston Scientific Neuromodulation Corporation System and method for estimating clustering of electrodes in neurostimulation system
8805519, Sep 30 2010 CRG SERVICING LLC, Systems and methods for detecting intrathecal penetration
8812128, Nov 17 2010 Boston Scientific Neuromodulation Corporation Implantable neurostimulator-initiated status notification
8825172, Jul 27 2012 Boston Scientific Neuromodulation Corporation Techniques for electronically assessing electrode condition and peri-electrode tissue conductivity change pre- and post-MRI
8849411, May 17 2011 Boston Scientific Neuromodulation Corporation User-defined graphical shapes used as a visualization aid for stimulator programming
8868188, Sep 20 2012 Boston Scientific Neuromodulation Corporation Method for treating hypertension via electrical stimulation of neural structures
8914120, Oct 01 2012 Boston Scientific Neuromodulation Corporation Method for treating depression by indirectly stimulating raphe nuclei
8918987, Jan 11 2005 Boston Scientific Neuromodulation Corporation Electrode array assembly and method of making same
8923975, Dec 09 2011 Boston Scientific Neuromodulation Corporation Method for direct modulation of the dorsolateral funiculus
8934979, Dec 27 2010 Boston Scientific Neuromodulation Corporation Neurostimulation system for selectively estimating volume of activation and providing therapy
8965482, Sep 30 2010 CRG SERVICING LLC, Systems and methods for positioning implanted devices in a patient
8977360, May 13 2011 Boston Scientific Neuromodulation Corporation Neurostimulation system with on-effector programmer control
9002459, Sep 19 2012 Boston Scientific Neuromodulation Corporation Method for selectively modulating neural elements in the dorsal horn
9089705, Dec 07 2012 Boston Scientific Neuromodulation Corporation Neurostimulation system with three-dimensional lead migration detection and automatic neurostimulation correction
9101768, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
9126046, Jun 25 2012 Boston Scientific Neuromodulation Corporation Neurostimulation system for enabling magnetic field sensing with a shut-down hall sensor
9168378, Dec 09 2011 Boston Scientific Neuromodulation Corporation Methods and devices for treatment of non-neuropathic conditions using electrical stimulation
9180297, May 16 2013 Boston Scientific Neuromodulation Corporation System and method for spinal cord modulation to treat motor disorder without paresthesia
9220901, Mar 16 2012 Boston Scientific Neuromodulation Corporation Neurostimulation system for preventing magnetically induced currents in electronic circuitry
9289609, Dec 27 2010 Boston Scientific Neuromodulation Corporation Neurostimulation system for selectively estimating volume of activation and providing therapy
9308022, Dec 10 2012 CRG SERVICING LLC, Lead insertion devices and associated systems and methods
9308369, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
9327128, Oct 30 2013 Boston Scientific Neuromodulation Corporation Automatic anode and cathode fractional control and location to selectively avoid dorsal root stimulation
9333361, Oct 31 2013 Boston Scientific Neuromodulation Corporation System and method to automatically incorporate lead information from medical image into programmable user interface
9339655, Jun 30 2012 Boston Scientific Neuromodulation Corporation System and method for compounding low-frequency sources for high-frequency neuromodulation
9345891, Sep 30 2010 Nevro Corporation Systems and methods for positioning implanted devices in a patient
9358388, Sep 30 2010 CRG SERVICING LLC, Systems and methods for detecting intrathecal penetration
9358394, Apr 04 2013 Boston Scientific Neuromodulation Corporation Management of stimulation safety limits in a neurostimulation system
9358396, Nov 01 2013 Boston Scientific Neuromodulation Corporation Systems and methods for delivering sub-threshold therapy to a patient at a physiological midline
9358398, May 27 2011 Boston Scientific Neuromodulation Corporation Collection of clinical data for graphical representation and analysis
9381359, Feb 05 2014 Boston Scientific Neuromodulation Corporation; Dongchul, Lee System and method for delivering modulated sub-threshold therapy to a patient
9381360, Feb 05 2014 Boston Scientific Neuromodulation Corporation System and method for delivering modulated sub-threshold therapy to a patient
9403015, Jun 29 2012 Boston Scientific Neuromodulation Corporation High frequency neuromodulation system and method for reducing energy requirements
9403020, Oct 04 2011 CRG SERVICING LLC, Modeling positions of implanted devices in a patient
9415223, Nov 02 2009 Boston Scientific Neuromodulation Corporation Charge recovery bi-phasic control for tissue stimulation
9421376, Dec 21 2012 Boston Scientific Neuromodulation Corporation Systems and methods for adjusting electrical neuromodulation therapy in medication therapeutic window
9421379, Feb 25 2014 Boston Scientific Neuromodulation Corporation Neuromodulation system incorporating multivariate sensing, multivariable pattern recognition, and patient specific adaptation
9433782, Dec 04 2012 Boston Scientific Neuromodulation Corporation Implantable medical device having electromagnetic interference filter device to reduce pocket tissue heating
9440076, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
9440079, May 13 2011 Boston Scientific Neuromodulation Corporation Management of stimulation safety limits in a neurostimulation system
9446239, Mar 16 2012 Boston Scientific Neuromodulation Corporation Field augmented current steering using voltage sources
9492665, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
9501829, Mar 29 2011 Boston Scientific Neuromodulation Corporation System and method for atlas registration
9511222, Aug 03 2012 Boston Scientific Neuromodulation Corporation System and method for post-stroke neural rehabilitation
9511229, Jun 28 2011 Boston Scientific Neuromodulation Corporation System and method for using impedance to determine proximity and orientation of segmented electrodes
9526902, May 15 2008 Boston Scientific Neuromodulation Corporation VOA generation system and method using a fiber specific analysis
9533148, Feb 21 2014 Boston Scientific Neuromodulation Corporation Neurostimulation system and method for automatically adjusting stimulation and reducing energy requirements using evoked action potential
9545510, Feb 12 2008 Intelect Medical, Inc. Directional lead assembly with electrode anchoring prongs
9550062, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
9561379, Jun 05 2012 Boston Scientific Neuromodulation Corporation Neurostimulation system with default MRI-mode
9561380, Aug 28 2012 Boston Scientific Neuromodulation Corporation Point-and-click programming for deep brain stimulation using real-time monopolar review trendlines
9592389, May 27 2011 Boston Scientific Neuromodulation Corporation Visualization of relevant stimulation leadwire electrodes relative to selected stimulation information
9597517, Jul 03 2014 Boston Scientific Neuromodulation Corporation Neurostimulation system with flexible patterning and waveforms
9604058, Apr 06 2012 Boston Scientific Neuromodulation Corporation Method for achieving low-back spinal cord stimulation without significant side-effects
9604067, Aug 04 2012 Boston Scientific Neuromodulation Corporation Techniques and methods for storing and transferring registration, atlas, and lead information between medical devices
9616230, Dec 12 2013 Boston Scientific Neuromodulation Corporation Systems and methods for programming a neuromodulation system
9616233, Aug 29 2013 Boston Scientific Neuromodulation Corporation Systems and method of adjusting the compliance voltage in a neuromodulation device
9623246, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
9623250, Jun 28 2013 Boston Scientific Neuromodulation Corporation Electrode selection for sub-threshold modulation therapy
9643015, May 27 2011 Boston Scientific Neuromodilation Corporation Collection of clinical data for graphical representation and analysis
9643017, Aug 28 2012 Boston Scientific Neuromodulation Corporation Capture and visualization of clinical effects data in relation to a lead and/or locus of stimulation
9656084, Apr 25 2014 Boston Scientific Neuromodulation Corporation System and method for electrical pulse charge compensation for implantable medical device capacitance loading effects
9656085, Sep 23 2014 Boston Scientific Neuromodulation Corporation Systems and methods for receiving user-provided selection of electrode lists
9662495, Jul 24 2014 Boston Scientific Neuromodulation Corporation Enhanced dorsal horn stimulation using multiple electrical fields
9669221, Oct 31 2013 Boston Scientific Neuromodulation Corporation System to detect lead location from medical image
9669222, Oct 30 2013 Boston Scientific Neuromodulation Corporation Automatic anode and cathode fractional control and location to selectively avoid dorsal root stimulation
9694183, Mar 15 2013 Boston Scientific Neuromodulation Corporation Neuromodulation system and method for providing multiple modulation patterns in a single channel
9694184, Jun 29 2012 Boston Scientific Neuromodulation Corporation High frequency neuromodulation system and method for reducing energy requirements
9713720, Dec 07 2012 Boston Scientific Neuromodulation Corporation Neurostimulation system with three-dimensional lead migration detection and automatic neurostimulation correction
9717899, Jan 11 2005 Boston Scientific Neuromodulation Corporation Method of manufacturing a stimulation lead
9731115, Aug 04 2012 Boston Scientific Neuromodulation Corporation System and method for muscle reconditioning and neural rehabilitation
9737715, Sep 23 2014 Boston Scientific Neuromodulation Corporation Perception calibration of neural tissue using field troll
9737717, Sep 15 2014 Boston Scientific Neuromodulation Corporation Graphical user interface for programming neurostimulation pulse patterns
9744345, Dec 21 2012 Boston Scientific Neuromodulation Corporation Leads with proximal stiffening and related methods of use and manufacture
9744362, Apr 04 2013 Boston Scientific Neuromodulation Corporation Management of stimulation safety limits in a neurostimulation system
9760688, Jul 07 2004 Cleveland Clinic Foundation Method and device for displaying predicted volume of influence
9764141, Sep 23 2014 Boston Scientific Neuromodulation Corporation Neuromodulation with burst stimulation
9776003, Dec 02 2009 The Cleveland Clinic Foundation Reversing cognitive-motor impairments in patients having a neuro-degenerative disease using a computational modeling approach to deep brain stimulation programming
9792412, Nov 01 2012 Boston Scientific Neuromodulation Corporation Systems and methods for VOA model generation and use
9802052, Nov 04 2014 Boston Scientific Neuromodulation Corporation Method and apparatus for programming complex neurostimulation patterns
9814880, Sep 23 2014 Boston Scientific Neuromodulation Corporation Short pulse width stimulation
9821167, Aug 28 2012 Boston Scientific Neuromodulation Corporation Point-and-click programming for deep brain stimulation using real-time monopolar review trendlines
9827422, May 28 2015 Boston Scientific Neuromodulation Corporation Neuromodulation using stochastically-modulated stimulation parameters
9844674, Feb 05 2014 Boston Scientific Neuromodulation Corporation System and method for delivering modulated sub-threshold therapy to a patient
9849287, Feb 09 2015 Boston Scientific Neuromodulation Corporation System and method for determining the neurological position of epidural leads
9855432, Oct 28 2010 Boston Scientific Neuromodulation Corporation System and method for providing fluid real-time visualization of region of tissue activation
9867989, Jun 14 2010 Boston Scientific Neuromodulation Corporation Programming interface for spinal cord neuromodulation
9872986, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
9872992, Mar 16 2012 Boston Scientific Neuromodulation Corporation System and method for estimating location and depth of stimulation leads
9872997, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
9878170, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
9887574, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
9925380, Jul 24 2014 Boston Scientific Neuromodulation Corporation Enhanced dorsal horn stimulation using multiple electrical fields
9925382, Aug 09 2011 Boston Scientific Neuromodulation Corporation Systems and methods for stimulation-related volume analysis, creation, and sharing
9937349, Dec 12 2013 Boston Scientific Neuromodulation Corporation Systems and methods for programming a neuromodulation system
9950172, May 13 2011 Boston Scientific Neuromodulation Corporation Management of stimulation safety limits in a neurostimulation system
9950173, Jun 06 2013 Boston Scientific Neuromodulation Corporation System and method for delivering sub-threshold and super-threshold therapy to a patient
9956409, Mar 15 2013 CIRTEC MEDICAL CORP Spinal cord stimulator system
9956419, May 26 2015 Boston Scientific Neuromodulation Corporation Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation
9959388, Jul 24 2014 Boston Scientific Neuromodulation Corporation Systems, devices, and methods for providing electrical stimulation therapy feedback
9959940, Nov 01 2012 Boston Scientific Neuromodulation Corporation Systems and methods for VOA model generation and use
9974959, Oct 07 2014 Boston Scientific Neuromodulation Corporation Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters
9974960, Apr 04 2013 Boston Scientific Neuromodulation Corporation Management of stimulation safety limits in a neurostimulation system
9993646, Sep 23 2014 Boston Scientific Neuromodulation Corporation Sub-perception modulation responsive to patient input
Patent Priority Assignee Title
3769984,
4379462, Oct 29 1980 ADVANCED NEUROMODULATION SYSTEMS, INC Multi-electrode catheter assembly for spinal cord stimulation
4953564, Aug 23 1989 Medtronic, Inc. Screw-in drug eluting lead
5555618, Oct 12 1993 Arrow International, Inc Method of making electrode-carrying catheter
6055456, Apr 29 1999 Medtronic, Inc. Single and multi-polar implantable lead for sacral nerve electrical stimulation
6205361, Feb 10 1998 Boston Scientific Neuromodulation Corporation Implantable expandable multicontact electrodes
6216045, Apr 26 1999 ADVANCED NEUROMODULATION SYSTEMS, INC Implantable lead and method of manufacture
6249708, Aug 26 1997 ELA MEDICAL, S A Fluted channel construction for a multi-conductor catheter lead
6551302, Sep 24 1997 HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT Steerable catheter with tip alignment and surface contact detector
6847849, Nov 15 2000 MAMO, LAURA Minimally invasive apparatus for implanting a sacral stimulation lead
20050215945,
//////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Mar 21 2007PIANCA, ANNE M Advanced Bionics CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0190520627 pdf
Mar 21 2007KUZMA, JANUSZ A Advanced Bionics CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0190520627 pdf
Mar 21 2007WALTER, JERYLE L Advanced Bionics CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0190520627 pdf
Mar 22 2007Boston Scientific Neuromodulation Corporation(assignment on the face of the patent)
Mar 22 2007GIRGIS, MILADAdvanced Bionics CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0190520627 pdf
Nov 16 2007Advanced Bionics CorporationBoston Scientific Neuromodulation CorporationCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0202960477 pdf
Date Maintenance Fee Events
Feb 25 2015M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Feb 28 2019M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Feb 21 2023M1553: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Sep 13 20144 years fee payment window open
Mar 13 20156 months grace period start (w surcharge)
Sep 13 2015patent expiry (for year 4)
Sep 13 20172 years to revive unintentionally abandoned end. (for year 4)
Sep 13 20188 years fee payment window open
Mar 13 20196 months grace period start (w surcharge)
Sep 13 2019patent expiry (for year 8)
Sep 13 20212 years to revive unintentionally abandoned end. (for year 8)
Sep 13 202212 years fee payment window open
Mar 13 20236 months grace period start (w surcharge)
Sep 13 2023patent expiry (for year 12)
Sep 13 20252 years to revive unintentionally abandoned end. (for year 12)